ici 136,753 has been researched along with valproate sodium in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Howard, HR; Koe, BK; Sarges, R; Weissman, A | 1 |
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
2 other study(ies) available for ici 136,753 and valproate sodium
| Article | Year |
|---|---|
A novel class of "GABAergic" agents: 1-aryl-3-(aminoalkylidene)oxindoles.
Topics: 3-Mercaptopropionic Acid; Animals; Flunitrazepam; Indoles; Male; Mice; Receptors, GABA-A; Structure-Activity Relationship; Sulfhydryl Compounds | 1989 |
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |